SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali

Autor: Sylvain Laverdure, Donatien Kazadi, Kadidia Kone, Viviane Callier, Djeneba Dabitao, Dehkontee Dennis, Mory Cherif Haidara, Sally Hunsberger, Olivier Tshiani Mbaya, Renee Ridzon, Irini Sereti, Katy Shaw-Saliba, Esther Akpa, Fatoumata Binta Bah, Yi-Chi Barash, Abdoul Habib Beavogui, Jean-Luc Biampata, Tyler Bonnett, Shawn Brown, Alissa Burkey, Daouda Camara, Sekou Camara, Elfrida Cline-Cole, Mamadou D Coulibaly, Nadie Coulibaly, Robin Dewar, Mountaga Diallo, Samba Diarra, Seydou Doumbia, Allison Eyler, Karine Fouth Tchos, Alyson Francis, Louis Grue, Helene Highbarger, Jeroen Highbarger, Augustin Mbala Ibanda, Kadé Kallon, Esaie Luzolu Kindombe, Placide Mbala Kingebeni, Cece Francis Kolié, Perrine Lallemand, Caeul Lim, Emmanuel Lokilo, Raphael Lumembe, Ashley Louise McCormack, Laura McNay, Gael Mukendi, Thierry Mukendi, Jean Jacques Muyembe, Kevin Newell, Wissedi Njoh, Isaac Balmayel Pankwa, Elisabeth Pukuta, Yogolelo Riziki, Adam Rupert, Seydou Samake, Jennifer Sandrus, Adama Sangare, Mary Smolskis, Gema Souto Adeva, Randy Stevens, Cheick Oumar Tangara, Moctar Tounkara, Meghan Trumbull-Kennedy, Antoine Tshomba, Mamadou Wague, Shera Weyers, Chris Worthington

Publikováno v: International Journal of Infectious Diseases, Vol 142, Iss , Pp 106985- (2024)

Objectives: The InVITE study, starting in August 2021, was designed to examine the immunogenicity of different vaccine regimens in several countries including the Democratic Republic of Congo, Guinea, Liberia, and Mali. Prevaccination baseline sample

Externí odkaz: https://doaj.org/article/4880684a1ab54f1c8059cdc0b84e49b3